Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Chief Legal Officer & Corp Sec | September 08, 2026 | September 11, 2026 |
| Covista Inc.ATGE · Entity 3964 | SVP, CLO and Secretary | August 23, 2017 | August 25, 2017 |
| Skyward Specialty Insurance Group, Inc.SKWD · Entity 4400 | Director | May 11, 2026 | May 12, 2026 |
| XPO, Inc.XPO · Entity 3242 | Director | January 04, 2021 | January 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date September 08, 2026 · Filed September 11, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,238 |
Last balance in matching sequence
After 2026-09-08 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2026-09-08 · Sale · Disposed 293 · Balance 9,238 Row 2 · 2026-09-08 · Exercise / conversion · Acquired 6,833 · Balance 16,071 Row 3 · 2026-09-08 · Tax withholding · Disposed 2,769 · Balance 13,302 F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Row 4 · 2026-09-08 · Sale · Disposed 4,064 · Balance 9,238 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.96 · Expires 2035-05-20 | Direct | 35,658 |
Reported balance
After 2026-09-08 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-09-08 · Exercise / conversion · Disposed 6,833 · Balance 35,658 F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.
Covista Inc.
Report date August 23, 2017 · Filed August 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,420 |
Reported balance
After 2017-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-23 · Grant · Acquired 4,420 · Balance 4,420 F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date. |
| Incentive Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 11,796 |
Reported balance
After 2017-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-23 · Grant · Acquired 11,796 · Balance 11,796 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 3,129 |
Reported balance
After 2017-08-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-23 · Grant · Acquired 3,129 · Balance 3,129 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date.
F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations.
Skyward Specialty Insurance Group, Inc.
Report date May 11, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,570 |
Ending reported balance
After 2026-05-11 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-05-11 · Exercise / conversion · Acquired 1,797 · Balance 5,310 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. Row 2 · 2026-05-11 · Sale · Disposed 100 · Balance 5,210 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 3 · 2026-05-11 · Sale · Disposed 140 · Balance 5,070 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 4 · 2026-05-11 · Sale · Disposed 500 · Balance 4,570 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. |
| 2025 RSU AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-11 · Exercise / conversion · Disposed 1,797 · Balance 0 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026. F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4.
F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026.
F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window.
XPO, Inc.
Report date January 04, 2021 · Filed January 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,604 |
Reported balance
After 2021-01-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-01-04 · Grant · Acquired 1,604 · Balance 1,604 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,392 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,392 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,249 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,249 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,071 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,071 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,970 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,970 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,716 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,716 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock.
F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer.
F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GXO Logistics, Inc.
Report date May 13, 2025 · Filed May 15, 2025
Section 16 reporting ended · disclosed 2025-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,380 |
Reported balance
After 2025-05-13 transaction · row 1
1 source rowRow 1 · 2025-05-13 · Exercise / conversion · Acquired 3,617 · Balance 12,380 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-13 · Exercise / conversion · Disposed 3,617 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock.
F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2020 Filed Jun 4, 2020 23:17 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 691 | $52.76 | $36,459.79 |
DisclosureSEC source: 0001209191-20-034561 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,489 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units and restricted stock units (the "Bonus RSUs") received in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the Bonus RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:17 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 1,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032703 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,180 F1 · shares: Represents the issuance of restricted stock units (the "RSUs") in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
| May 06, 2020 Filed May 7, 2020 21:59 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 14,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027767 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,199 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2021 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:18 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 2,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-20-000009 · wf-form4_157834907943260.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,392 Underlying: Common Stock, par value $0.001 per share · 2,392 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: The RSUs shall vest on January 4, 2021, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest on January 4, 2021, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| July 19, 2019 Filed Jul 23, 2019 22:35 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 5,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-042981 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,766 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on August 15, 2020 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:00 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 3,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-19-000007 · wf-form4_154663922830471.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,249 Underlying: Common Stock, par value $0.001 per share · 3,249 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2020, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2020, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 00:53 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 2,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-18-000009 · wf-form4_151502721279218.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,071 Underlying: Common Stock, par value $0.001 per share · 2,071 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2019, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2019, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 01:26 UTC | Covista Inc. ATGE · Entity 3964 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 3,129 | $0.00 Strike: $33.90 | $0.00 |
DisclosureSEC source: 0001127602-17-026447 · form4.xml · derivative · entry 3 Ashe Gena L · CIK 0001669943 · SVP, CLO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,129 Underlying: Common Stock · 3,129 shares Expires 2027-08-23 F2 · derivative.exercise_date: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 01:26 UTC | Covista Inc. ATGE · Entity 3964 | GrantIncentive Stock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $33.90 | $0.00 |
DisclosureSEC source: 0001127602-17-026447 · form4.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · SVP, CLO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2027-08-23 F2 · derivative.exercise_date: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 01:26 UTC | Covista Inc. ATGE · Entity 3964 | GrantCommon Stock | 4,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-026447 · form4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · SVP, CLO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,420 F1 · security: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date. Read SEC document |
| March 06, 2017 Filed Mar 9, 2017 00:29 UTC Amendment | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-17-000026 · wf-form4a_148901937903181.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Underlying: Common Stock, par value $0.001 per share · 2,716 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: This grant of RSUs was awarded to the Reporting Person for her services as director of the Issuer during 2016. The RSUs shall vest on January 1, 2018, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: This grant of RSUs was awarded to the Reporting Person for her services as director of the Issuer during 2016. The RSUs shall vest on January 1, 2018, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:37 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-17-000025 · wf-form4_148900901454888.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Underlying: Common Stock, par value $0.001 per share · 2,716 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: This grant of RSUs was awarded to the Reporting Person for her services as director of the Issuer during 2016. The RSUs shall vest on January 1, 2018, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: This grant of RSUs was awarded to the Reporting Person for her services as director of the Issuer during 2016. The RSUs shall vest on January 1, 2018, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 23:58 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-17-000007 · wf-form4_148357430941277.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,970 Underlying: Common Stock, par value $0.001 per share · 3,970 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: The RSUs shall vest on January 3, 2018, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest on January 3, 2018, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.